Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Cancer Research
Published October 6, 2026
Pancreatic Cancer KRAS Breakthrough: Drug Graveyard No More.
October 7, 2026
Medspoke
Medspoke
Journal of Hepatology
Published October 6, 2026
00:00
--:--
First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: P...
October 7, 2026
Share
First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.
https://www.medspoke.co/channel_journal?id=785&tap_id=15143
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Gut
Published October 6, 2026
Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and valida...
October 7, 2026
Why are you reporting this TALK?
